(Q44383228)

2 December 2017

The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation (English)

1 reference

2 December 2017

1 reference

5

Ljungman P

1 reference

2 December 2017

Nilsson C

1

1 reference

2 December 2017

Aschan J

2

1 reference

2 December 2017

Hentschke P

3

1 reference

2 December 2017

Ringdén O

4

1 reference

2 December 2017

Hassan M

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Bone Marrow Transplantation

2 December 2017

1 reference

2 December 2017

31

1 reference

2 December 2017

429-435

1 reference

2 December 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703896

2 December 2017

0 references

cites work

Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

[Interstitial pneumopathies caused by busulfan. Histologic, developmental and bronchoalveolar lavage analysis of 3 cases].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

Pharmacokinetics of liposomal busulphan in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

Metronidazole and antipyrine as probes for the study of foreign compound metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

Cytochrome P450 isozymes and antiepileptic drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

Clinically significant pharmacokinetic drug interactions with carbamazepine. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

Metabolism of 14C-busulfan in isolated perfused rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

Comparison of the sensitivity of human and rat hepatocytes to the genotoxic effects of metronidazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

Ketobemidone may alter busulfan pharmacokinetics during high-dose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

7 January 2021

Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

7 January 2021

An improved limited sampling method for individualised busulphan dosing in bone marrow transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

7 January 2021

Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

7 January 2021

Why metronidazole is active against both bacteria and parasites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

7 January 2021

Gas chromatographic determination of busulfan in plasma with electron-capture detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

7 January 2021

Venoocclusive disease of the liver following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

7 January 2021

Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

7 January 2021

Metabolism of metronidazole and antipyrine in isolated rat hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

7 January 2021

Pharmacokinetic and metabolic studies of high-dose busulphan in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

7 January 2021

Binding of 3H-metronidazole in olfactory, respiratory and alimentary epithelia in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703896

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703896

1 reference

2 December 2017

1 reference